Freehold Royalties is rated Strong Buy, offering resilient exposure to high-quality North American oil and gas royalty assets and attractive long-term upside. FRHLF’s robust free cash flow, cost-light ...
We have launched coverage of Royalty Pharma, the largest buyer of biopharmaceutical royalties with a portfolio of more than 35 commercial products and 10 development-stage product candidates. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results